300151 Shenzhen Changhong Technology
- 16.34
- -0.54-3.20%
Shenzhen Changhong Technology News
Shenzhen Changhong Technology (stock code 300151.SZ): Zhejiang Baimingsheng and Fresenius Medical Care sign a strategic cooperation framework agreement.
Changhong Technology (300151.SZ) announced on June 5 that its subsidiary, Zhejiang Baiming Sheng Medical Technology Co., Ltd. ("Zhejiang Baiming Sheng"), and Fresenius Medical Care Deutschland GmbH (Fresenius Medical Care) signed a strategic cooperation framework agreement on June 4, 2024. The company has been working with Fresenius Medical Care since 2020, and the cooperation areas include high-polymer medical consumables products such as blood dialysis medical consumables and medical device components. The revenue amounts of the past three years account for the company's medical business.
Optimism for Shenzhen Changhong Technology (SZSE:300151) Has Grown This Past Week, Despite Five-year Decline in Earnings
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far more than 100% on a really good stock. For example, the Shenzhen Changhong Techno
Changhong Technology (300151.SZ) plans to pay 0.5 yuan for 10 shares to be deducted from interest on May 29
Zhitong Finance App News, Changhong Technology (300151.SZ) announced that the company's 2023 equity distribution plan: 0.5 yuan (tax included) for every 10 shares to all shareholders; the exclusion date is: May 29, 2024.
Changhong Technology (300151.SZ): The company is not involved in the field of synthetic biology
Gelonghui May 13 丨 Changhong Technology (300151.SZ) said on the investor interactive platform that the company is not involved in the field of synthetic biology yet.
Changhong Technology (300151.SZ): Actual controller Li Huanchang has increased his holdings by 127,400 shares more than half of the increase period
Gelonghui, April 30, 丨 Changhong Technology (300151.SZ) announced that as of the disclosure date of this announcement, the plan to increase holdings was over halfway. From February 1, 2024 to April 30, 2024, Mr. Li Huanchang, the controlling shareholder and actual controller of the company, increased his holdings of the company's shares by 127,400 shares through centralized bidding through the Shenzhen Stock Exchange trading system, accounting for 0.02% of the company's total share capital. The increase amount was RMB 1,646,600.
Changhong Technology (300151.SZ): Net profit of 249.59,900 yuan in the first quarter decreased by 21.01% year-on-year
Gelonghui, April 26 | Changhong Technology (300151.SZ) released its first quarter report. Operating revenue was 233 million yuan, down 18.11% year on year, net profit of 249.599 million yuan, down 21.01% year on year, after deducting non-net profit of 17.14 million yuan, down 34.95% year on year, with basic earnings of 0.05 yuan per share.
Shenzhen Changhong Technology Co., Ltd.'s (SZSE:300151) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Shenzhen Changhong Technology (SZSE:300151) has had a rough month with its share price down 13%. However, stock prices are usually driven by a company's financials over the long term, which in this
After the Recent Decline, Shenzhen Changhong Technology Co., Ltd. (SZSE:300151) CEO Huanchang Li's Holdings Have Lost 4.7% of Their Value
Key Insights Insiders appear to have a vested interest in Shenzhen Changhong Technology's growth, as seen by their sizeable ownership A total of 6 investors have a majority stake in the company with
Changhong Technology (300151.SZ) will list and circulate 30 million restricted shares on March 14
Changhong Technology (300151.SZ) announced that the company issued restricted shares to specific targets. The number of restricted shares has now been lifted...
Returns On Capital Signal Tricky Times Ahead For Shenzhen Changhong Technology (SZSE:300151)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Ideally, a business will show two trends; firstly a growing return on capital emp
Changhong Technology (300151.SZ) received 88,900 shares from actual controller Li Huanchang
Changhong Technology (300151.SZ) announced that Li Huanchang, the controlling shareholder and actual controller of the company, in February 2024...
Changhong Technology (300151.SZ): 2023 net profit pre-reduced by 64.81%-73.41%
Gelonghui, January 30, 丨 Changhong Technology (300151.SZ) announced its 2023 annual results forecast. Net profit profit attributable to shareholders of listed companies during the reporting period was 34 million yuan to 45 million yuan, down 73.41%-64.81% from the same period last year; net profit profit after deducting non-recurring profit and loss was 22.3 million yuan - 33.3 million yuan, down 81.31%-72.09% from the same period last year. Reasons for changes in performance: 1. Affected by factors such as weakness in the medical testing industry, shrinking market demand, and customer inventory removal. During the reporting period, the company
Revenues Not Telling The Story For Shenzhen Changhong Technology Co., Ltd. (SZSE:300151)
When you see that almost half of the companies in the Machinery industry in China have price-to-sales ratios (or "P/S") below 2.7x, Shenzhen Changhong Technology Co., Ltd. (SZSE:300151) looks to be gi
Do Its Financials Have Any Role To Play In Driving Shenzhen Changhong Technology Co., Ltd.'s (SZSE:300151) Stock Up Recently?
Most readers would already be aware that Shenzhen Changhong Technology's (SZSE:300151) stock increased significantly by 19% over the past three months. As most would know, fundamentals are what usua
Changhong Technology (300151.SZ) plans to increase the capital of Vietnam's Sun Company by 20 million US dollars to expand production base
Changhong Technology (300151.SZ) announced that the company intends to use its own capital or self-financing to pass the company's wholly-owned subsidiary, Germany...
Is Shenzhen Changhong Technology (SZSE:300151) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
Changhong Technology to Buy 5% of Swiss Pharma Firm PharmaSens For 3.4 Million Francs
Shenzhen Changhong Technology (SHE:300151) has agreed to acquire a 5% stake in Swiss pharmaceutical company PharmaSens in a deal worth 3.4 million Swiss francs. The Chinese injection molding company w
Changhong Technology (300151.SZ): Desheng Investment plans to subscribe for 335.69 million newly issued registered shares of PharmaSens
On December 7, Gelonghui Technology (300151.SZ) announced that Desheng Investment Co., Ltd. (“Desheng Investment”), a wholly-owned subsidiary of the company, intends to subscribe for 33,569 new registered shares of PharmaSens AG (“PharmaSens”) at an issue price of 100 Swiss francs per share. It is expected to account for 5% of its total share capital after issuance, with a transaction amount of 3,356,900 Swiss francs (the specific amount is based on the actual exchange rate calculation on the day of remittance). The investment subscription capital for this investment comes from Desheng Investment's own capital. The company's current investment is based on economics
Shenzhen Changhong Technology (SZSE:300151) Will Be Hoping To Turn Its Returns On Capital Around
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in c
Changhong Technology (300151.SZ): The company is stepping up product development for wafer carriers
Gelonghui November 3 | Changhong Technology (300151.SZ) said on the investor interactive platform that the company is stepping up product research and development of wafer carriers. Recently, Dinglong Weibai, a subsidiary of the company, has signed a framework procurement agreement with a major domestic customer manufacturer to begin providing certified products. An official order can only be obtained once the verification is passed. The specific progress is subject to the company's announcement.
Analysis
Price Target
No Data
